Our Strategy for Changing Healthcare

Origination

Leveraging on our proprietary deal flow, we apply an active, fundamentals-driven approach to develop deep conviction and identify and engage companies that are best positioned to emerge as market leaders:

• Brand(s), services & products with proven business models
• Solid financial and operational performance that generate strong, regular and sustainable cash flows
• Potential for margin improvement through operational enhancement
• Strong management team with successful track record
• Mission of providing affordable and quality healthcare for all

Execution

At Quadria Capital, we have a comprehensive due diligence procedure above and beyond the standard processes that is unique to healthcare businesses including:

• Assessing management
• Evaluating underlying clinical standards
• Identifying value drivers
• Creating a fully articulated bottom-up model
• Building a value creation plan

Value Creation

We leverage our industry knowledge, operational experience, and extensive network to unlock and create value throughout the investment lifecycle. With a “hands-on approach”, the team drives initiatives from strategy setting to frontline implementation. In every investment, we work side by side with portfolio companies to help them become more productive, efficient, and valuable via:

• Defined value creation methodology
• Dedicated group of operating partners
• Proprietary, global relationships across the healthcare ecosystem
• Realised synergies across the portfolio including cross-portfolio partnerships, knowledge sharing and procurement synergies

Exit

Effective exit planning is an important element of every investment and we believe that exiting at the right time is critical to realise optimal value. To do this, even during pre-investment, exit timing and options are considered and planned.

We proactively manage, position, and develop portfolio companies with a well-examined strategy to groom them into attractive acquisition targets, ensuring on-track exit.

Exit opportunities include strategic sales and IPOs, often at premium valuations, reflecting the underlying growth and expansion of the portfolio company.